Coegin Pharma's Nomination Committee appointed for the 2027 Annual General Meeting
The Nomination Committee of Coegin Pharma AB ("Coegin") has been appointed in accordance with the guidelines adopted at the Annual General Meeting on May 21, 2026.
The following individuals have been appointed as members of the Nomination Committee for the 2027 Annual General Meeting:
Ulrika Arver, representing Alveco Invest AB.
Anna Svenstig, representing Bengt Svenstig.
Lennart Börjesson, representing his own shareholdings.
Eva Sjökvist Saers, in her capacity as Chair of the Board of Directors of Coegin.
The Nomination Committee is tasked with performing the duties assigned to it under the Swedish Corporate Governance Code. The Committee is responsible for preparing proposals for the 2027 Annual General Meeting regarding the Chair of the Meeting, members of the Board of Directors, the Chair of the Board, the auditor, board and auditor remuneration, as well as any potential changes to the guidelines for the Nomination Committee.
The Annual General Meeting will be held on May 26, 2027, in Lund, Sweden. Shareholders who wish to submit proposals to the Nomination Committee are welcome to do so no later than January 20, 2027. Proposals should be sent via email to [email protected].
The Nomination Committee's proposals will be presented in the notice convening the Annual General Meeting and on the company's website, www.coeginpharma.com.
For further information, please contact:
Jens Eriksson, CEO, or Lars B. Rasmussen, CFO
Email: [email protected]
Phone: +46 72 221 24 21
About Coegin Pharma
Coegin Pharma is a Swedish innovation company developing and commercializing advanced cosmetic technologies for hair and skin. Its flagship innovation, Follicopeptide®, is a patented, clinically developed peptide technology targeting hair thinning, commercialized through selected partners and the Company's VEXIENNE® brand. Coegin is also developing NPP-4, a next-generation cosmetic peptide innovation for skin tone enhancement.
With proprietary peptide technology, scalable in-house production and flexible commercial models, Coegin is building a differentiated platform for science-based cosmetic products.
Coegin Pharma's share is listed on NGM Growth Market and dual-listed on Börse Stuttgart. The Company is headquartered in Lund, Sweden.
For more information, including company updates and social media links, visit coeginpharma.com
Filer
Filer
Om Coegin Pharma
Coegin Pharma är ett svenskt innovationsbolag som utvecklar och kommersialiserar avancerade kosmetiska teknologier för hår och hud.
Prenumerera
Få löpande information från Coegin Pharma via e-post.